MGA - morinlab/LLMPP GitHub Wiki


bibliography: 'morinlab.bib' csl: 'NLM.csl' link-citations: true

MGA

Overview

MGA acts as a transcriptional repressor and interacts with MYC, a well-known oncogene. Mutations in MGA have been described in DLBCL.1 One study suggested MGA mutations were more common in DLBCLs in patients of African ancestry.2 The mutation pattern in MGA is consistent with a role as a tumour suppressor gene.

History

%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
timeline
    title Publication timing
      2017-07-27 : Jallades : MZL
      2017-10-10 : Reddy : DLBCL
Loading

Relevance tier by entity

Entity Tier Description
MZL 2 relevance in MZL not firmly established[@jalladesExomeSequencingIdentifies2017]
DLBCL 1 high-confidence DLBCL gene[@reddyGeneticFunctionalDrivers2017]

Mutation incidence in large patient cohorts (GAMBL reanalysis)

Entity source frequency (%)
DLBCL GAMBL genomes 4.02
DLBCL Schmitz cohort 7.23
DLBCL Reddy cohort 4.70
DLBCL Chapuy cohort 3.42

Mutation pattern and selective pressure estimates

Entity aSHM Significant selection dN/dS (missense) dN/dS (nonsense)
DLBCL No No 1.432 12.504
BL No No 2.443 3.733
FL No No 0.000 0.000

View coding variants in ProteinPaint hg19 or hg38

View all variants in GenomePaint hg19 or hg38

MGA Expression

References

⚠️ **GitHub.com Fallback** ⚠️